Full-Time

Regional Director

Women's Health Sales

Confirmed live in the last 24 hours

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions

Biotechnology
Healthcare

Compensation Overview

$230k - $245kAnnually

Senior

Atlanta, GA, USA

Covering territories in Georgia and South Carolina.

Category
Strategic Account Management
Sales & Account Management
Required Skills
Marketing
Excel/Numbers/Sheets
Requirements
  • BA in Business, Marketing or related field is required; MBA preferred.
  • Background in medical or biological sciences; clinical diagnostics preferred.
  • Minimum three years’ physician sales experience in diagnostic laboratory business (preferably in a genetics laboratory).
  • Minimum of 5 years’ successful sales management experience preferably in diagnostic laboratory business.
  • Proficient in Microsoft PowerPoint and Excel; Gmail; Sales Force.com.
Responsibilities
  • Educating and recruiting Key Opinion Leaders from the OBGYN medical community.
  • You will become an expert in Natera’s technology and service offerings and be able to represent the company and its business interests: physicians and hospitals.
  • Develop and execute plans to ensure rapid distribution of all products.
  • Develop business plans based on sales goals, expectations and available resources, including regional strategies and tactics.
  • The position includes recruiting, selecting, hiring and coordinating the training of all sales professionals within your region.
  • Effectively provide constructive feedback to sales professionals in order to help maximize their potential.
  • Spend a sufficient amount of time, as defined by the VP, in the field with sales professionals in order to help them develop, as well as provide direction and feedback.
  • Provide direction based on field input, market assessments and trends in order to develop a region which is consistently implementing 'Best Practices'.
  • Plan, design and implement territory alignment based on maximum ROI.
  • Support sales professionals by providing guidance and career development.
  • Establish positive working relationships with all key customer segments (internal and external).

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care through precise genetic insights.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

12%

1 year growth

27%

2 year growth

66%
Simplify Jobs

Simplify's Take

What believers are saying

  • Natera's continuous innovation, such as the launch of the Prospera Heart test with DQS, demonstrates its commitment to improving patient outcomes and maintaining market leadership.
  • The company's diverse product offerings across oncology, transplant health, and women's health provide multiple revenue streams and reduce dependency on a single market.
  • Significant investments from entities like Massachusetts Financial Services Co. MA indicate strong financial backing and confidence in Natera's growth potential.

What critics are saying

  • Allegations of deceptive sales and billing practices could damage Natera's reputation and lead to legal and financial repercussions.
  • The highly competitive nature of the genetic testing market requires constant innovation and differentiation to maintain market share.

What makes Natera unique

  • Natera's focus on cell-free DNA (cfDNA) technology for a wide range of applications, from oncology to prenatal screening, sets it apart from competitors who may specialize in only one area.
  • The introduction of unique features like the Donor Quantity Score (DQS) for transplant rejection detection enhances the accuracy and reliability of their tests, distinguishing them from other genetic testing companies.
  • Natera's extensive portfolio of over 200 peer-reviewed publications underscores its commitment to scientific validation and credibility, which is a significant competitive advantage.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks